Yoo W - Search Results

1

Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil.

Yeon JE, Yoo W, Hong SP, Chang YJ, Yu SK, Kim JH, Seo YS, Chung HJ, Moon MS, Kim SO, Byun KS, Lee CH. Yeon JE, et al. Among authors: yoo w. Gut. 2006 Oct;55(10):1488-95. doi: 10.1136/gut.2005.077099. Epub 2006 Feb 4. Gut. 2006. PMID: 16461777 Free PMC article.

2

Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.

Kim HS, Han KH, Ahn SH, Kim EO, Chang HY, Moon MS, Chung HJ, Yoo W, Kim SO, Hong SP. Kim HS, et al. Among authors: yoo w. Antivir Ther. 2005;10(3):441-9. Antivir Ther. 2005. PMID: 15918335

3

Predominance of hepatitis B virus YMDD mutants is prognostic of viral DNA breakthrough.

Lee CH, Kim SO, Byun KS, Moon MS, Kim EO, Yeon JE, Yoo W, Hong SP. Lee CH, et al. Among authors: yoo w. Gastroenterology. 2006 Apr;130(4):1144-52. doi: 10.1053/j.gastro.2006.01.005. Gastroenterology. 2006. PMID: 16618409

4

Virologic response at 12 months of treatment predicts sustained antiviral efficacy in patients with adefovir-treated Lamivudine-resistant chronic hepatitis B.

Jung YK, Yeon JE, Han WS, Kim JH, Kim JH, Park JJ, Kim JS, Bak YT, Yoo W, Hong SP, Kim SO, Kwon SY, Byun KS, Lee CH. Jung YK, et al. Among authors: yoo w. Gut Liver. 2010 Jun;4(2):212-8. doi: 10.5009/gnl.2010.4.2.212. Epub 2010 Jun 16. Gut Liver. 2010. PMID: 20559524 Free PMC article.

5

Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance.

Cho SW, Koh KH, Cheong JY, Lee MH, Hong SP, Yoo WD, Kim SO. Cho SW, et al. Among authors: yoo wd. J Viral Hepat. 2010 Mar;17(3):171-7. doi: 10.1111/j.1365-2893.2009.01161.x. Epub 2009 Aug 12. J Viral Hepat. 2010. PMID: 19678894

6

[Association between CCR5 promoter polymorphisms and hepatitis B virus infection].

Chang HY, Ahn SH, Kim DY, Shin JS, Kim YS, Hong SP, Chung HJ, Kim SO, Yoo WD, Han KH. Chang HY, et al. Korean J Hepatol. 2005 Jun;11(2):116-24. Korean J Hepatol. 2005. PMID: 15980670 Korean.

7

[Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients].

Cho JH, Cheong JY, Kang JK, Park JS, Lee MH, Lim NK, Hong SP, Kim SO, Yoo WD, Cho SW. Cho JH, et al. Korean J Hepatol. 2008 Mar;14(1):58-66. doi: 10.3350/kjhep.2008.14.1.58. Korean J Hepatol. 2008. PMID: 18367858 Korean.

8

Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.

Cheong JY, Cho SW, Yoo JH, Hong SP, Kim SO, Yoo WD, Kim JH. Cheong JY, et al. Hepatogastroenterology. 2008 May-Jun;55(84):1029-33. Hepatogastroenterology. 2008. PMID: 18705323

9

Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.

Cha CK, Kwon HC, Cheong JY, Cho SW, Hong SP, Kim SO, Yoo WD. Cha CK, et al. J Med Virol. 2009 Mar;81(3):417-24. doi: 10.1002/jmv.21402. J Med Virol. 2009. PMID: 19152409 Free article.

10

Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy.

Kwon HC, Cheong JY, Cho SW, Choi JM, Hong SP, Kim SO, Yoo WD. Kwon HC, et al. J Gastroenterol Hepatol. 2009 Jan;24(1):49-54. doi: 10.1111/j.1440-1746.2008.05570.x. J Gastroenterol Hepatol. 2009. PMID: 19196395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,115 results

Search Page

Filters